Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
There is no difference in the complication or re-operation rates between tension band wiring and locking plate fixation for olecranon fractures. The findings of a multicentre study.
Oputa TJ, Plastow R, Kennedy J, Jain N; North West Olecranon Fracture Study Group. Oputa TJ, et al. Among authors: jain n. Arch Orthop Trauma Surg. 2022 Nov;142(11):3341-3345. doi: 10.1007/s00402-021-04159-6. Epub 2021 Sep 28. Arch Orthop Trauma Surg. 2022. PMID: 34581860 Review.
An aide-mémoire for tibial plateau fractures.
Thurston MD, Guyver PM, Jain NP, Toms AD. Thurston MD, et al. Among authors: jain np. Ann R Coll Surg Engl. 2014 Jul;96(5):386. doi: 10.1308/rcsann.2014.96.5.386. Ann R Coll Surg Engl. 2014. PMID: 24992425 Free PMC article. No abstract available.
Correction to: There is no difference in the complication or re-operation rates between tension band wiring and locking plate fixation for olecranon fractures. The findings of a multicentre study.
Oputa TJ, Plastow R, Kennedy J, Jain N; North West Olecranon Fracture Study Group. Oputa TJ, et al. Among authors: jain n. Arch Orthop Trauma Surg. 2022 Nov;142(11):3347. doi: 10.1007/s00402-021-04235-x. Arch Orthop Trauma Surg. 2022. PMID: 34748056 No abstract available.
Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Gibson A, Nunez C, Robusto L, Kammerer B, Garcia M, Roth M, Sheth R, Tewari P, Hittle A, Toepfer L, Torres R, Short NJ, Jabbour E, Jain N, Cuglievan B, McCall D. Gibson A, et al. Among authors: jain n. Haematologica. 2024 May 23. doi: 10.3324/haematol.2023.284950. Online ahead of print. Haematologica. 2024. PMID: 38779719 Free article.
3,656 results